Cite
Lederer K, Parvathaneni K, Painter MM, et al. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. medRxiv. 2021;doi: 10.1101/2021.09.16.21263686.
Lederer, K., Parvathaneni, K., Painter, M. M., Bettini, E., Agarwal, D., Lundgreen, K. A., Weirick, M., Goel, R. R., Xu, X., Drapeau, E. M., Gouma, S., Greenplate, A. R., Coz, C. L., Romberg, N., Jones, L., Rosen, M., Besharatian, B., Kaminiski, M., Weiskopf, D., Sette, A., Hensley, S. E., Bates, P., Wherry, E. J., Naji, A., Bhoj, V., & Locci, M. (2021). Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.09.16.21263686
Lederer, Katlyn, et al. "Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.09.16.21263686
Lederer K, Parvathaneni K, Painter MM, Bettini E, Agarwal D, Lundgreen KA, Weirick M, Goel RR, Xu X, Drapeau EM, Gouma S, Greenplate AR, Coz CL, Romberg N, Jones L, Rosen M, Besharatian B, Kaminiski M, Weiskopf D, Sette A, Hensley SE, Bates P, Wherry EJ, Naji A, Bhoj V, Locci M. Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals. medRxiv. 2021 Sep 21; doi: 10.1101/2021.09.16.21263686. PMID: 34580676; PMCID: PMC8475965.
Copy
Download .nbib